(Q79901810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

adult acute myeloid leukemia

26 December 2019

main subject

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

G Visani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

A Olivieri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

M Malagola

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

M Brunori

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

P P Piccaluga

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

D Capelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

G Pomponio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

G Martinelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

G Sparaventi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

P Leoni

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

1091-1102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

Evidence-based medicine and treatment choices

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

21 January 2018

Evidence-based medicine

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Finding and applying evidence during clinical rounds: the "evidence cart".

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Analysis of the National Institutes of Health Medicare coverage assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

21 January 2018

Evidence based practice

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Purine nucleoside analogues in the treatment of myleoid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (H

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Hematopoietic stem cell transplantation for hematological malignancies in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

The randomized controlled trial gets a middle-aged checkup

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500513595

10.1080/10428190500513595

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16840201%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference